The controversial impact of B cells subsets on immune response to pneumococcal vaccine in HIV-1 patients

Background: Chronic HIV infection leads to severe perturbations of the B cell populations and hypo-responsiveness to vaccines. The associations between circulating B cell subpopulations and the antibody response to pneumococcal polysaccharide vaccine in antiretroviral-naïve and treated patients were...

Full description

Bibliographic Details
Main Authors: Olga Tsachouridou, Lemonia Skoura, Pantelis Zebekakis, Apostolia Margariti, Adamantini Georgiou, Michael Daniilidis, Nikolaos Malisiovas, Symeon Metallidis
Format: Article
Language:English
Published: Elsevier 2015-09-01
Series:International Journal of Infectious Diseases
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971215001757
_version_ 1819170844418506752
author Olga Tsachouridou
Lemonia Skoura
Pantelis Zebekakis
Apostolia Margariti
Adamantini Georgiou
Michael Daniilidis
Nikolaos Malisiovas
Symeon Metallidis
author_facet Olga Tsachouridou
Lemonia Skoura
Pantelis Zebekakis
Apostolia Margariti
Adamantini Georgiou
Michael Daniilidis
Nikolaos Malisiovas
Symeon Metallidis
author_sort Olga Tsachouridou
collection DOAJ
description Background: Chronic HIV infection leads to severe perturbations of the B cell populations and hypo-responsiveness to vaccines. The associations between circulating B cell subpopulations and the antibody response to pneumococcal polysaccharide vaccine in antiretroviral-naïve and treated patients were studied. Methods: Sixty-six HIV-infected adults were grouped according to antiretroviral therapy (ART) and CD4+ cell count; 31 were ART-naïve and 35 were ART-treated, and they were matched for age, CD4 cell count, and duration of HIV infection. All subjects were immunized with the 23-valent polysaccharide vaccine against Streptococcus pneumoniae. Pre- and post-vaccination B cell subpopulations were assessed by flow cytometry. Serum IgG concentrations for vaccine serotypes were quantified by ELISA at baseline and at 4 and 48 weeks post-vaccination. Results: Patients under highly active antiretroviral therapy (HAART) had significantly higher antibody levels against pneumococcal vaccine antigens, while an adequate number of patients responded to vaccination. Memory B cells were diminished over time, although treated patients maintained higher levels of all subsets studied, with the exception of activated memory and isotype-switched memory B cells. Conclusions: Low concentrations of total B cells and exhausted memory B cells was the strongest independent predictor of poor pneumococcal vaccine responsiveness, emphasizing that B cell subset disturbances are associated with a poor vaccine response among HIV-infected patients.
first_indexed 2024-12-22T19:41:51Z
format Article
id doaj.art-5a8d185ba06245fe9d79dddc8579de5b
institution Directory Open Access Journal
issn 1201-9712
1878-3511
language English
last_indexed 2024-12-22T19:41:51Z
publishDate 2015-09-01
publisher Elsevier
record_format Article
series International Journal of Infectious Diseases
spelling doaj.art-5a8d185ba06245fe9d79dddc8579de5b2022-12-21T18:14:50ZengElsevierInternational Journal of Infectious Diseases1201-97121878-35112015-09-0138C243110.1016/j.ijid.2015.07.008The controversial impact of B cells subsets on immune response to pneumococcal vaccine in HIV-1 patientsOlga Tsachouridou0Lemonia Skoura1Pantelis Zebekakis2Apostolia Margariti3Adamantini Georgiou4Michael Daniilidis5Nikolaos Malisiovas6Symeon Metallidis71st Internal Medicine Department, Infectious Diseases Division, Medical School, Aristotle University of Thessaloniki, 1, Stilponos Kyriakidi Str, 54636, Thessaloniki, Greece1st Internal Medicine Department, Infectious Diseases Division, Medical School, Aristotle University of Thessaloniki, 1, Stilponos Kyriakidi Str, 54636, Thessaloniki, Greece1st Internal Medicine Department, Infectious Diseases Division, Medical School, Aristotle University of Thessaloniki, 1, Stilponos Kyriakidi Str, 54636, Thessaloniki, GreeceNational AIDS Reference Centre of Northern Greece, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece1st Internal Medicine Department, Infectious Diseases Division, Medical School, Aristotle University of Thessaloniki, 1, Stilponos Kyriakidi Str, 54636, Thessaloniki, Greece1st Internal Medicine Department, Infectious Diseases Division, Medical School, Aristotle University of Thessaloniki, 1, Stilponos Kyriakidi Str, 54636, Thessaloniki, GreeceNational AIDS Reference Centre of Northern Greece, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece1st Internal Medicine Department, Infectious Diseases Division, Medical School, Aristotle University of Thessaloniki, 1, Stilponos Kyriakidi Str, 54636, Thessaloniki, GreeceBackground: Chronic HIV infection leads to severe perturbations of the B cell populations and hypo-responsiveness to vaccines. The associations between circulating B cell subpopulations and the antibody response to pneumococcal polysaccharide vaccine in antiretroviral-naïve and treated patients were studied. Methods: Sixty-six HIV-infected adults were grouped according to antiretroviral therapy (ART) and CD4+ cell count; 31 were ART-naïve and 35 were ART-treated, and they were matched for age, CD4 cell count, and duration of HIV infection. All subjects were immunized with the 23-valent polysaccharide vaccine against Streptococcus pneumoniae. Pre- and post-vaccination B cell subpopulations were assessed by flow cytometry. Serum IgG concentrations for vaccine serotypes were quantified by ELISA at baseline and at 4 and 48 weeks post-vaccination. Results: Patients under highly active antiretroviral therapy (HAART) had significantly higher antibody levels against pneumococcal vaccine antigens, while an adequate number of patients responded to vaccination. Memory B cells were diminished over time, although treated patients maintained higher levels of all subsets studied, with the exception of activated memory and isotype-switched memory B cells. Conclusions: Low concentrations of total B cells and exhausted memory B cells was the strongest independent predictor of poor pneumococcal vaccine responsiveness, emphasizing that B cell subset disturbances are associated with a poor vaccine response among HIV-infected patients.http://www.sciencedirect.com/science/article/pii/S1201971215001757B cell subsetsMemory cellsHIV-1 infectionAntibody responsePhagocytosis
spellingShingle Olga Tsachouridou
Lemonia Skoura
Pantelis Zebekakis
Apostolia Margariti
Adamantini Georgiou
Michael Daniilidis
Nikolaos Malisiovas
Symeon Metallidis
The controversial impact of B cells subsets on immune response to pneumococcal vaccine in HIV-1 patients
International Journal of Infectious Diseases
B cell subsets
Memory cells
HIV-1 infection
Antibody response
Phagocytosis
title The controversial impact of B cells subsets on immune response to pneumococcal vaccine in HIV-1 patients
title_full The controversial impact of B cells subsets on immune response to pneumococcal vaccine in HIV-1 patients
title_fullStr The controversial impact of B cells subsets on immune response to pneumococcal vaccine in HIV-1 patients
title_full_unstemmed The controversial impact of B cells subsets on immune response to pneumococcal vaccine in HIV-1 patients
title_short The controversial impact of B cells subsets on immune response to pneumococcal vaccine in HIV-1 patients
title_sort controversial impact of b cells subsets on immune response to pneumococcal vaccine in hiv 1 patients
topic B cell subsets
Memory cells
HIV-1 infection
Antibody response
Phagocytosis
url http://www.sciencedirect.com/science/article/pii/S1201971215001757
work_keys_str_mv AT olgatsachouridou thecontroversialimpactofbcellssubsetsonimmuneresponsetopneumococcalvaccineinhiv1patients
AT lemoniaskoura thecontroversialimpactofbcellssubsetsonimmuneresponsetopneumococcalvaccineinhiv1patients
AT panteliszebekakis thecontroversialimpactofbcellssubsetsonimmuneresponsetopneumococcalvaccineinhiv1patients
AT apostoliamargariti thecontroversialimpactofbcellssubsetsonimmuneresponsetopneumococcalvaccineinhiv1patients
AT adamantinigeorgiou thecontroversialimpactofbcellssubsetsonimmuneresponsetopneumococcalvaccineinhiv1patients
AT michaeldaniilidis thecontroversialimpactofbcellssubsetsonimmuneresponsetopneumococcalvaccineinhiv1patients
AT nikolaosmalisiovas thecontroversialimpactofbcellssubsetsonimmuneresponsetopneumococcalvaccineinhiv1patients
AT symeonmetallidis thecontroversialimpactofbcellssubsetsonimmuneresponsetopneumococcalvaccineinhiv1patients
AT olgatsachouridou controversialimpactofbcellssubsetsonimmuneresponsetopneumococcalvaccineinhiv1patients
AT lemoniaskoura controversialimpactofbcellssubsetsonimmuneresponsetopneumococcalvaccineinhiv1patients
AT panteliszebekakis controversialimpactofbcellssubsetsonimmuneresponsetopneumococcalvaccineinhiv1patients
AT apostoliamargariti controversialimpactofbcellssubsetsonimmuneresponsetopneumococcalvaccineinhiv1patients
AT adamantinigeorgiou controversialimpactofbcellssubsetsonimmuneresponsetopneumococcalvaccineinhiv1patients
AT michaeldaniilidis controversialimpactofbcellssubsetsonimmuneresponsetopneumococcalvaccineinhiv1patients
AT nikolaosmalisiovas controversialimpactofbcellssubsetsonimmuneresponsetopneumococcalvaccineinhiv1patients
AT symeonmetallidis controversialimpactofbcellssubsetsonimmuneresponsetopneumococcalvaccineinhiv1patients